Analysis of the effectiveness of the implementation of the pilot project of vaccination against pneumococcal infection in risk groups in the municipalities leading on indicators of mortality from community-acquired pneumonia

Abstract

There were established municipalities with the highest mortality rates from community-acquired pneumonia (CAP). When etiological deciphering of CAP confirmed the role of S. pneumoniae (Klein) Chester in the development and outcome of this disease. Among the risk contingents were vaccinated against pneumococcal disease, which had an impact on morbidity and mortality from CAP. It is proved that the vaccination of contingent risk against pneumococcal disease reduces the morbidity and mortality from CAP.